{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:59:19Z","timestamp":1788325159187,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jconrel.2022.08.025","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T12:40:14Z","timestamp":1661172014000},"page":"215-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Bioengineered immunomodulatory organelle targeted nanozymes for photodynamic immunometabolic therapy"],"prefix":"10.1016","volume":"350","author":[{"given":"Vishnu","family":"Sunil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Heng","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu Cadiam","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anbu","family":"Mozhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Hwa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jconrel.2022.08.025_bb0005","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1021\/acs.nanolett.9b00021","article-title":"Reprogramming tumor immune microenvironment (TIME) and metabolism via biomimetic targeting codelivery of shikonin\/JQ1","volume":"19","author":"Wang","year":"2019","journal-title":"Nano Lett."},{"issue":"17","key":"10.1016\/j.jconrel.2022.08.025_bb0010","doi-asserted-by":"crossref","first-page":"1900101","DOI":"10.1002\/advs.201900101","article-title":"Immunomodulatory nanosystems","volume":"6","author":"Feng","year":"2019","journal-title":"Advanced Science"},{"issue":"14","key":"10.1016\/j.jconrel.2022.08.025_bb0015","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1039\/C8CS00896E","article-title":"Recent advances in nanomaterial-based synergistic combination cancer immunotherapy","volume":"48","author":"Sang","year":"2019","journal-title":"Chem. Soc. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2022.08.025_bb0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2022.08.025_bb0025","doi-asserted-by":"crossref","first-page":"120974","DOI":"10.1016\/j.biomaterials.2021.120974","article-title":"Convection enhanced delivery of light responsive antigen capturing oxygen generators for chemo-phototherapy triggered adaptive immunity","volume":"275","author":"Sunil","year":"2021","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.jconrel.2022.08.025_bb0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41565-020-00844-6","article-title":"Photoacoustic molecular imaging-escorted adipose photodynamic\u2013browning synergy for fighting obesity with virus-like complexes","volume":"16","author":"Chen","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"10.1016\/j.jconrel.2022.08.025_bb0035","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.18632\/oncotarget.14425","article-title":"Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity","volume":"8","author":"Ogawa","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.jconrel.2022.08.025_bb0040","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1021\/acs.bioconjchem.9b00547","article-title":"The effect of antibody fragments on CD25 targeted regulatory T cell near-infrared photoimmunotherapy","volume":"30","author":"Okada","year":"2019","journal-title":"Bioconjug. Chem."},{"issue":"12","key":"10.1016\/j.jconrel.2022.08.025_bb0045","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/nm.2554","article-title":"Cancer cell\u2013selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules","volume":"17","author":"Mitsunaga","year":"2011","journal-title":"Nat. Med."},{"issue":"6428","key":"10.1016\/j.jconrel.2022.08.025_bb0050","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jconrel.2022.08.025_bb0055","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/jbm.a.36723","article-title":"An injectable scaffold based on temperature-responsive hydrogel and factor-loaded nanoparticles for application in vascularization in tissue engineering","volume":"107","author":"He","year":"2019","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"8","key":"10.1016\/j.jconrel.2022.08.025_bb0060","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41571-020-0352-8","article-title":"Moving towards personalized treatments of immune-related adverse events","volume":"17","author":"Esfahani","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.jconrel.2022.08.025_bb0065","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","article-title":"Navigating metabolic pathways to enhance antitumour immunity and immunotherapy","volume":"16","author":"Li","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.jconrel.2022.08.025_bb0070","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41573-019-0032-5","article-title":"Targeting metabolism to regulate immune responses in autoimmunity and cancer","volume":"18","author":"Patel","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2022.08.025_bb0075","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jconrel.2020.02.043","article-title":"Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer","volume":"321","author":"Liu","year":"2020","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2022.08.025_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-01847-4","article-title":"What is the prospect of indoleamine 2, 3-dioxygenase 1 inhibition in cancer? Extrapolation from the past","volume":"40","author":"Yao","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.jconrel.2022.08.025_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019823","article-title":"The indoleamine-2, 3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells","volume":"6","author":"Opitz","year":"2011","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.jconrel.2022.08.025_bb0090","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1111\/febs.12444","article-title":"The expanding roles of 1-methyl-tryptophan (1-MT): in addition to inhibiting kynurenine production, 1-MT activates the synthesis of melatonin in skin cells","volume":"280","author":"Moreno","year":"2013","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.jconrel.2022.08.025_bb0095","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrc2639","article-title":"Inhibitors of indoleamine-2, 3-dioxygenase for cancer therapy: can we see the wood for the trees?","volume":"9","author":"L\u00f6b","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"7368","key":"10.1016\/j.jconrel.2022.08.025_bb0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jconrel.2022.08.025_bb0105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrc3237","article-title":"Combining immunotherapy and targeted therapies in cancer treatment","volume":"12","author":"Vanneman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"47","key":"10.1016\/j.jconrel.2022.08.025_bb0110","doi-asserted-by":"crossref","first-page":"14854","DOI":"10.1021\/jacs.5b10182","article-title":"A Pt (IV) pro-drug preferentially targets indoleamine-2, 3-dioxygenase, providing enhanced ovarian cancer immuno-chemotherapy","volume":"137","author":"Awuah","year":"2015","journal-title":"J. Am. Chem. Soc."},{"issue":"38","key":"10.1016\/j.jconrel.2022.08.025_bb0115","doi-asserted-by":"crossref","first-page":"1803001","DOI":"10.1002\/adma.201803001","article-title":"Binary cooperative prodrug nanoparticles improve immunotherapy by synergistically modulating immune tumor microenvironment","volume":"30","author":"Feng","year":"2018","journal-title":"Adv. Mater."},{"issue":"17","key":"10.1016\/j.jconrel.2022.08.025_bb0120","doi-asserted-by":"crossref","first-page":"1800025","DOI":"10.1002\/adfm.201800025","article-title":"iRGD modified chemo-immunotherapeutic nanoparticles for enhanced immunotherapy against glioblastoma","volume":"28","author":"Kuang","year":"2018","journal-title":"Adv. Funct. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2022.08.025_bb0125","doi-asserted-by":"crossref","first-page":"2000026","DOI":"10.1002\/sstr.202000026","article-title":"Recent Progress on Activatable nanomedicines for Immunometabolic combinational Cancer therapy","volume":"1","author":"Zhang","year":"2020","journal-title":"Small Structures"},{"issue":"3","key":"10.1016\/j.jconrel.2022.08.025_bb0130","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1021\/acs.bioconjchem.7b00719","article-title":"Enzymes as immunotherapeutics","volume":"29","author":"Farhadi","year":"2017","journal-title":"Bioconjug. Chem."},{"issue":"12","key":"10.1016\/j.jconrel.2022.08.025_bb0135","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2215\/CJN.00150118","article-title":"Pharmacology behind common drug nephrotoxicities","volume":"13","author":"Perazella","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.jconrel.2022.08.025_bb0140","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1681\/ASN.2017080882","article-title":"Causes of death after a hospitalization with AKI","volume":"29","author":"Silver","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.jconrel.2022.08.025_bb0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00685326","article-title":"WR2721 as a modulator of cisplatin-and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach","volume":"33","author":"Treskes","year":"1993","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"7","key":"10.1016\/j.jconrel.2022.08.025_bb0150","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/bjp.2008.15","article-title":"N-acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats","volume":"153","author":"Chen","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.08.025_bb0155","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.addr.2018.07.002","article-title":"Drug delivery systems for programmed and on-demand release","volume":"132","author":"Davoodi","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.08.025_bb0160","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jconrel.2020.05.005","article-title":"Enhanced penetration of pro-apoptotic and anti-angiogenic micellar nanoprobe in 3D multicellular spheroids for chemophototherapy","volume":"323","author":"Mozhi","year":"2020","journal-title":"J. Control. Release"},{"issue":"51","key":"10.1016\/j.jconrel.2022.08.025_bb0165","doi-asserted-by":"crossref","first-page":"24380","DOI":"10.1021\/jp055584b","article-title":"Shape-selective synthesis and oxygen storage behavior of ceria nanopolyhedra, nanorods, and nanocubes","volume":"109","author":"Mai","year":"2005","journal-title":"J. Phys. Chem. B"},{"issue":"50","key":"10.1016\/j.jconrel.2022.08.025_bb0170","doi-asserted-by":"crossref","first-page":"12579","DOI":"10.1002\/anie.201207587","article-title":"Using thermally regenerable cerium oxide nanoparticles in biocomputing to perform label-free, resettable, and colorimetric logic operations","volume":"51","author":"Lin","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"issue":"27","key":"10.1016\/j.jconrel.2022.08.025_bb0175","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4592","key":"10.1016\/j.jconrel.2022.08.025_bb0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1126\/science.6828875","article-title":"Mechanical measurement of red cell membrane thickness","volume":"220","author":"Hochmuth","year":"1983","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jconrel.2022.08.025_bb0185","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7150\/thno.17259","article-title":"Enhanced blood suspensibility and laser-activated tumor-specific drug release of theranostic mesoporous silica nanoparticles by functionalizing with erythrocyte membranes","volume":"7","author":"Su","year":"2017","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.jconrel.2022.08.025_bb0190","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/ijms19020436","article-title":"When immune cells turn bad\u2014tumor-associated microglia\/macrophages in glioma","volume":"19","author":"Roesch","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2022.08.025_bb0195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.08.025_bb0200","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-065X.2008.00607.x","article-title":"The yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance","volume":"222","author":"Allavena","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2022.08.025_bb0205","doi-asserted-by":"crossref","first-page":"2105932","DOI":"10.1002\/adfm.202105932","article-title":"3D printing personalized, Photocrosslinkable hydrogel wound dressings for the treatment of thermal burns","author":"Teoh","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.08.025_bb0210","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neuroscience.2015.07.086","article-title":"Organotypic brain slice cultures: a review","volume":"305","author":"Humpel","year":"2015","journal-title":"Neuroscience"},{"issue":"14","key":"10.1016\/j.jconrel.2022.08.025_bb0215","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S1359-6446(05)03502-6","article-title":"Organotypic cultures as tools for functional screening in the CNS","volume":"10","author":"Sundstrom","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"36","key":"10.1016\/j.jconrel.2022.08.025_bb0220","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.2174\/092986710794183042","article-title":"Organotypic cultures as tools for testing neuroactive drugs-link between in-vitro and in-vivo experiments","volume":"17","author":"Drexler","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"12","key":"10.1016\/j.jconrel.2022.08.025_bb0225","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1158\/1078-0432.CCR-12-3314","article-title":"Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages","volume":"19","author":"Bloch","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2022.08.025_bb0230","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2008.00635.x","article-title":"Strategies for use of IL-10 or its antagonists in human disease","volume":"223","author":"O\u2019Garra","year":"2008","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2022.08.025_bb0235","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.1711000104","article-title":"The migration of cells through chronically inflamed tissues","volume":"100","author":"Smith","year":"1970","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.jconrel.2022.08.025_bb0240","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/1523-1747.ep12349010","article-title":"Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model","volume":"106","author":"Lukas","year":"1996","journal-title":"J. Investig. Dermatol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.08.025_bb0245","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.0022-202x.2001.01631.x","article-title":"A close-up view of migrating Langerhans cells in the skin","volume":"118","author":"Stoitzner","year":"2002","journal-title":"J. Investig. Dermatol."},{"issue":"39","key":"10.1016\/j.jconrel.2022.08.025_bb0250","doi-asserted-by":"crossref","first-page":"33532","DOI":"10.1021\/acsami.8b10081","article-title":"Immune adjuvant targeting micelles allow efficient dendritic cell migration to lymph nodes for enhanced cellular immunity","volume":"10","author":"Yang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"10.1016\/j.jconrel.2022.08.025_bb0255","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1002\/eji.201040523","article-title":"Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN-\u03b1","volume":"40","author":"Rouzaut","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2022.08.025_bb0260","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1084\/jem.20081211","article-title":"The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells","volume":"206","author":"Maddaluno","year":"2009","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2022.08.025_bb0265","first-page":"12","article-title":"Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state","volume":"63","author":"De Vries","year":"2003","journal-title":"Cancer Res."},{"issue":"42","key":"10.1016\/j.jconrel.2022.08.025_bb0270","doi-asserted-by":"crossref","first-page":"1703303","DOI":"10.1002\/adfm.201703303","article-title":"Nutlin-3a and cytokine co-loaded Spermine-modified Acetalated dextran nanoparticles for Cancer chemo-immunotherapy","volume":"27","author":"Bauleth-Ramos","year":"2017","journal-title":"Adv. Funct. Mater."},{"issue":"9","key":"10.1016\/j.jconrel.2022.08.025_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074198","article-title":"Synergistic effect between amoxicillin and TLR ligands on dendritic cells from amoxicillin-delayed allergic patients","volume":"8","author":"Sanchez-Quintero","year":"2013","journal-title":"PLoS One"},{"issue":"33","key":"10.1016\/j.jconrel.2022.08.025_bb0280","doi-asserted-by":"crossref","first-page":"9224","DOI":"10.1016\/j.biomaterials.2014.07.050","article-title":"Surface chemistry dependent immunostimulative potential of porous silicon nanoplatforms","volume":"35","author":"Shahbazi","year":"2014","journal-title":"Biomaterials"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:28:25Z","timestamp":1759163305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922005302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":56,"alternative-id":["S0168365922005302"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.025","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioengineered immunomodulatory organelle targeted nanozymes for photodynamic immunometabolic therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}